Curogram is a technology company.
Curogram has raised $2.0M across 1 funding round.
Curogram has raised $2.0M in total across 1 funding round.
Curogram has raised $2.0M in total across 1 funding round.
Curogram's investors include 8-Bit Capital, Coelius Capital, Foundry Group, FPV Fund, Glencrest Group, Khosla Ventures, Operator Collective, Y Combinator, Joshua Reeves.
Curogram is a HIPAA-compliant communication platform that streamlines patient engagement for medical practices of all sizes, including large group practices and individual offices.[1][2][3] It builds an all-in-one solution featuring 2-way texting, smart reminders, online forms, telemedicine, reputation management, and a patient-centric mobile app, integrating seamlessly with any EMR/EHR in under 30 minutes to reduce no-shows by up to 75%, boost front-desk productivity by 35%, cut phone calls and staffing costs, and improve patient satisfaction.[1][2][3] Serving healthcare providers, it solves front-office inefficiencies like manual scheduling, communication silos, and administrative burdens, enabling practices to focus on care while driving revenue through better utilization and online reviews.[2][3]
Curogram emerged as a response to fragmented patient communication in medical offices, aiming to create a patient-centric healthcare messaging platform and universal patient portal.[1][4] While specific founders are not detailed in available sources, the company gained early traction during the COVID-19 pandemic, partnering with EPAM Systems in April 2020 to scale a telemedicine platform for mass screening, testing, and 2-way video chat, helping institutions like United Memorial Medical Center automate processes and reduce resource strain.[1] This crisis response marked a pivotal moment, showcasing its rapid deployment and adaptability, which propelled its evolution into a comprehensive engagement tool syncing with existing EMRs.[1][2]
Curogram rides the wave of digital patient engagement and telehealth expansion, accelerated by COVID-19, where demand for remote monitoring (RPM), e-prescribing, and automated scheduling surged to maintain care continuity while minimizing in-person risks.[1][5] Its timing aligns with market forces like rising healthcare staffing shortages, no-show rates averaging 20-30%, and EMR interoperability mandates, enabling practices to adopt RPM for real-time data sharing (e.g., glucose monitoring) and flexible communication preferences.[3][5] By influencing the ecosystem, Curogram standardizes front-office tech, fosters patient accountability, and supports profitability amid value-based care shifts, positioning it as a key enabler in a $100B+ patient engagement software market.[2][5]
Curogram is poised for accelerated growth by expanding into AI-driven personalization, advanced RPM integrations, and multi-language/global features to capture more of the underserved mid-sized practice segment.[2][3][5] Trends like hybrid care models, regulatory pushes for interoperability, and consumer demand for app-based health tools will amplify its momentum, potentially doubling productivity gains as telehealth normalizes post-pandemic.[1][5] Its influence may evolve from crisis responder to ecosystem backbone, powering widespread adoption of patient portals—ultimately redefining efficient, empathetic healthcare delivery as outlined in its core mission to transform practices.[3]
Curogram has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2019 | $2.0M Seed | 8-Bit Capital, Coelius Capital, Foundry Group, FPV Fund, Glencrest Group, Khosla Ventures, Operator Collective, Y Combinator, Joshua Reeves |